Northeast Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,761
Closed -$274K 177
2019
Q3
$274K Sell
2,761
-214
-7% -$20.3K 0.02% 155
2019
Q2
$275K Sell
2,975
-608
-17% -$57.7K 0.02% 155
2019
Q1
$338K Sell
3,583
-3,532
-50% -$309K 0.03% 134
2018
Q4
$456K Sell
7,115
-16,883
-70% -$1.25M 0.04% 114
2018
Q3
$2.15M Sell
23,998
-6,340
-21% -$560K 0.17% 78
2018
Q2
$2.41M Sell
30,338
-93,792
-76% -$7.79M 0.2% 77
2018
Q1
$11.1M Sell
124,130
-22,568
-15% -$2.17M 0.98% 37
2017
Q4
$15.3M Buy
146,698
+13,941
+11% +$1.57M 1.29% 32
2017
Q3
$19.4M Buy
132,757
+517
+0.4% +$70.4K 1.71% 17
2017
Q2
$17.2M Buy
132,240
+5,019
+4% +$615K 1.56% 24
2017
Q1
$15.8M Sell
127,221
-3,280
-3% -$393K 1.48% 26
2016
Q4
$15.1M Buy
130,501
+4,042
+3% +$450K 1.45% 26
2016
Q3
$13.2M Sell
126,459
-2,859
-2% -$309K 1.32% 33
2016
Q2
$12.8M Buy
129,318
+2,000
+2% +$207K 1.28% 35
2016
Q1
$12.7M Buy
127,318
+4,369
+4% +$450K 1.31% 35
2015
Q4
$14.7M Buy
122,949
+2,705
+2% +$313K 1.53% 26
2015
Q3
$13M Buy
120,244
+1,035
+0.9% +$128K 1.4% 27
2015
Q2
$13.8M Sell
119,209
-3,619
-3% -$414K 1.39% 28
2015
Q1
$14.2M Buy
122,828
+4,218
+4% +$504K 1.39% 27
2014
Q4
$13.3M Sell
118,610
-571
-0.5% -$60.2K 1.3% 30
2014
Q3
$11.3M Buy
119,181
+614
+0.5% +$55.4K 1.13% 32
2014
Q2
$10.2M Buy
118,567
+4,853
+4% +$369K 1.02% 36
2014
Q1
$7.94M Buy
113,714
+18,576
+20% +$1.47M 0.84% 45
2013
Q4
$8.04M Buy
95,138
+68,730
+260% +$5.44M 0.9% 39
2013
Q3
$2.04M Buy
+26,408
New +$1.85M 0.25% 80

Other funds holding CELG

Northeast Investment Management's CELG Position: Q4 2019 in Review

Northeast Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,761 shares — an estimated $274K sold.

Northeast Investment Management first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $19.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Northeast Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Northeast Investment Management sold 2,761 Celgene Corp shares in Q4 2019, an estimated $274K.
  • Northeast Investment Management first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
  • Northeast Investment Management's Celgene Corp position peaked at $19.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Northeast Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.